Literature DB >> 19409928

Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients.

Zoltan Varga1, Tunde Csepany, Ferenc Papp, Akos Fabian, Peter Gogolak, Agnes Toth, Gyorgy Panyi.   

Abstract

The membrane potential of human T cells is regulated by two potassium channels: the voltage-gated K(V)1.3 and the Ca2+-activated K(Ca)3.1. These two channels are essential for efficient antigenic activation and proliferation of T cells and are expressed at different levels in naïve, central memory and effector memory T cells. This provides the opportunity to inhibit the proliferation of the targeted subtype by channel-specific blocking compounds. Regulatory T cells (Tregs) also represent a unique subtype of T cells that perform highly specialized tasks in controlling immune responses, which raises the possibility that they too have a distinctive channel expression pattern. Using whole-cell patch-clamp we tested this hypothesis and determined the ion channel expression of CD4+CD25(hi)CD127(lo) regulatory and CD4+CD25(lo)CD127(hi) naïve T cells from the peripheral blood of healthy volunteers and multiple sclerosis (MS) patients sorted by flow cytometry. We have found that naïve and Treg cells from healthy controls expressed equal numbers of K(V)1.3 channels, while Tregs had a greater membrane surface as assessed by capacitance measurements, and consequentially lower channel density than naïve cells, indicating an "incomplete activation state" of Tregs. In contrast, Tregs from MS patients had fewer K(V)1.3 channels than naïve cells and there was no difference in the membrane capacitance or channel density between the two subtypes of cells. The expression level of K(Ca)3.1 channels was similar in all cell subsets. The observed differences in K(V)1.3 channel expression density may contribute to the varying responses upon antigenic stimulation by these cell types in health and disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19409928     DOI: 10.1016/j.imlet.2009.04.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

Review 1.  Ion channels and anti-cancer immunity.

Authors:  Gyorgy Panyi; Christine Beeton; Antonio Felipe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

2.  Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.

Authors:  Sascha Kahlfuß; Narasimhulu Simma; Judith Mankiewicz; Tanima Bose; Theresa Lowinus; Stefan Klein-Hessling; Rolf Sprengel; Burkhart Schraven; Martin Heine; Ursula Bommhardt
Journal:  Mol Cell Biol       Date:  2013-12-16       Impact factor: 4.272

3.  Unconventional EGF-induced ERK1/2-mediated Kv1.3 endocytosis.

Authors:  Ramón Martínez-Mármol; Núria Comes; Katarzyna Styrczewska; Mireia Pérez-Verdaguer; Rubén Vicente; Lluís Pujadas; Eduardo Soriano; Alexander Sorkin; Antonio Felipe
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

Review 4.  Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond.

Authors:  Verena Isabell Leussink; Xavier Montalban; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 5.  Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Authors:  Verena Hofschröer; Karolina Najder; Micol Rugi; Rayhana Bouazzi; Marco Cozzolino; Annarosa Arcangeli; Gyorgy Panyi; Albrecht Schwab
Journal:  Front Pharmacol       Date:  2021-01-19       Impact factor: 5.810

6.  Modulation of T lymphocyte calcium influx patterns via the inhibition of kv1.3 and ikca1 potassium channels in autoimmune disorders.

Authors:  Csaba Orbán; Enikõ Biró; Enikõ Grozdics; Anna Bajnok; Gergely Toldi
Journal:  Front Immunol       Date:  2013-08-06       Impact factor: 7.561

7.  Calcium Influx Characteristics During T Lymphocyte Activation Measured with Flow Cytometry.

Authors:  Enikő Birő; Barna Vásárhelyi; Gergely Toldi
Journal:  EJIFCC       Date:  2013-01-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.